Anna Ljung
Amministratore Delegato presso MOBERG PHARMA AB
Patrimonio netto: 1 971 $ in data 30/06/2024
Posizioni attive di Anna Ljung
Società | Posizione | Inizio | Fine |
---|---|---|---|
MOBERG PHARMA AB | Amministratore Delegato | 15/05/2019 | - |
Contatto Relazioni con gli Investitori | 01/01/2006 | - | |
Public Communications Contact | 01/01/2006 | - | |
Direttore Finanziario/CFO | 01/01/2006 | 15/05/2019 | |
SANA AB | Direttore/Membro del Consiglio | 19/01/2018 | - |
Independent Dir/Board Member | 19/01/2018 | - | |
ADDVISE GROUP AB | Direttore/Membro del Consiglio | 01/01/2022 | - |
Independent Dir/Board Member | 01/01/2022 | - | |
BIOSERGEN AB | Presidente | 14/06/2024 | - |
Saniona A/S
Saniona A/S Miscellaneous Commercial ServicesCommercial Services Part of Saniona AB, Saniona A/S is a Danish company dedicated to improving the lives of rare disease patients worldwide through scientific innovation. The company focuses on Prader-Willi Syndrome, a rare genetic disorder characterized by insatiable appetite, abnormal growth and body composition, low muscle tone, and social/emotional/cognitive deficits. Saniona is a leader in the discovery of highly specific ion channel modulators, which is a validated approach to treating diseases such as diabetes, hypertension, and epilepsy. The company's robust ion channel drug discovery engine has led to the development of San711, a first-in-class positive allosteric modulator of GABAA ?3 receptors, and San903, a potential first-in-class inhibitor of the calcium-activated potassium ion channel, KCA3.1, both of which are in development for rare neuropathic, inflammatory, and fibrotic disorders. | Direttore/Membro del Consiglio | - | - |
Moberg Derma Incentives AB | Presidente | - | - |
Storia della carriera di Anna Ljung
Precedenti posizioni note di Anna Ljung
Società | Posizione | Inizio | Fine |
---|---|---|---|
ONCOZENGE AB | Presidente | 01/01/2020 | 21/08/2023 |
Athera Biotechnologies AB
Athera Biotechnologies AB Pharmaceuticals: MajorHealth Technology Athera Biotechnologies AB operates as a biopharmaceutical company which focuses on developing targeted anti-inflammatory biological candidate drugs and companion diagnostics. It has a proprietary program the fully human antibody PC-mAb. The frim develops a biomarker and companion diagnostic CVDefine® kit. Its PC-mAb is a fully human monoclonal antibody which neutralizes a key driver of vascular inflammation, phosphorylcholine, which targets market of reducing secondary cardiovascular events, focusing on high-risk patients with low anti-PC levels. The company was founded by Johan Frostegard in 2002 and is headquartered in Stockholm, Sweden. | Direttore Finanziario/CFO | 01/01/2005 | 01/01/2006 |
Lipopetide AB | Comptroller/Controller/Auditor | - | - |
Direttore Finanziario/CFO | 01/01/2005 | 01/01/2006 | |
░░░░░░░░░ ░░░░░░ ░░░ ░░░░ ░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░ ░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
Formazione di Anna Ljung
Stockholm School of Economics | Graduate Degree |
Statistiche
Distribuzione geografica
Svezia | 10 |
Danimarca | 3 |
Stati Uniti | 2 |
Posizioni
Director/Board Member | 5 |
Director of Finance/CFO | 3 |
Chairman | 3 |
Settori
Health Technology | 7 |
Distribution Services | 3 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 5 |
---|---|
MOBERG PHARMA AB | Health Technology |
SANA AB | Health Technology |
ONCOZENGE AB | Health Technology |
ADDVISE GROUP AB | Distribution Services |
BIOSERGEN AB | Health Technology |
Aziende private | 6 |
---|---|
Athera Biotechnologies AB
Athera Biotechnologies AB Pharmaceuticals: MajorHealth Technology Athera Biotechnologies AB operates as a biopharmaceutical company which focuses on developing targeted anti-inflammatory biological candidate drugs and companion diagnostics. It has a proprietary program the fully human antibody PC-mAb. The frim develops a biomarker and companion diagnostic CVDefine® kit. Its PC-mAb is a fully human monoclonal antibody which neutralizes a key driver of vascular inflammation, phosphorylcholine, which targets market of reducing secondary cardiovascular events, focusing on high-risk patients with low anti-PC levels. The company was founded by Johan Frostegard in 2002 and is headquartered in Stockholm, Sweden. | Health Technology |
Lipopetide AB | |
Saniona A/S
Saniona A/S Miscellaneous Commercial ServicesCommercial Services Part of Saniona AB, Saniona A/S is a Danish company dedicated to improving the lives of rare disease patients worldwide through scientific innovation. The company focuses on Prader-Willi Syndrome, a rare genetic disorder characterized by insatiable appetite, abnormal growth and body composition, low muscle tone, and social/emotional/cognitive deficits. Saniona is a leader in the discovery of highly specific ion channel modulators, which is a validated approach to treating diseases such as diabetes, hypertension, and epilepsy. The company's robust ion channel drug discovery engine has led to the development of San711, a first-in-class positive allosteric modulator of GABAA ?3 receptors, and San903, a potential first-in-class inhibitor of the calcium-activated potassium ion channel, KCA3.1, both of which are in development for rare neuropathic, inflammatory, and fibrotic disorders. | Commercial Services |
Moberg Derma Incentives AB | |
Mpj Otc AB
Mpj Otc AB Pharmaceuticals: OtherHealth Technology Part of Moberg Pharma AB, Mpj Otc AB is a company that manufactures and distributes therapeutic medicines and personal products. | Health Technology |
Advantice Health LLC (New Jersey)
Advantice Health LLC (New Jersey) Medical DistributorsDistribution Services Advantice Health LLC manufactures and supplies therapeutic medicines and personal products. It is engaged in the marketing, sale and distribution of over-the-counter (OTC) medicines to drug stores, food stores, mass merchandisers, health professionals and international markets. It is best known for podiatrist recommended Kerasal One-Step Exfoliating Moisturizer Therapy. The company was founded in 2004 and is headquartered in Cedar Knolls, NJ. | Distribution Services |
- Borsa valori
- Insiders
- Anna Ljung
- Esperienza